About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Il4
interleukin 4
MGI:96556
105 phenotypes from 13 alleles in 27 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
C.129P2/OlaHsd-Il4/Il13tm3Anjm
abnormal interleukin-4 secretion J:91403
decreased IgE level J:91403
decreased interferon-gamma secretion J:91403
decreased interleukin-5 secretion J:91403
decreased interleukin-13 secretion J:91403
decreased susceptibility to autoimmune disorder J:91403
increased IgG2a level J:91403
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
C.Cg-Il4/Il13tm3Anjm
decreased susceptibility to injury J:88681
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
involves: 129P2/OlaHsd * BALB/c
abnormal mammary gland growth during pregnancy J:124116
abnormal splenocyte physiology J:60609
abnormal susceptibility to infection J:60609, J:131994
decreased IgG1 level J:178986
decreased inflammatory response J:60609, J:165513
ileum inflammation J:60609
increased susceptibility to parasitic infection J:60609
increased susceptibility to parasitic infection induced morbidity/mortality J:60609
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
involves: 129P2/OlaHsd * C57BL/6
abnormal immune system physiology J:89095
abnormal intestinal goblet cell morphology J:113543
abnormal splenocyte physiology J:72587
abnormal susceptibility to infection J:113543
abnormal T-helper 2 physiology J:89095
decreased IgE level J:72587, J:113543
decreased IgG1 level J:72587
decreased IgG level J:89095
decreased susceptibility to parasitic infection J:72587
granulomatous inflammation J:113543
increased eosinophil cell number J:113543
increased susceptibility to parasitic infection J:89095, J:113543
increased susceptibility to parasitic infection induced morbidity/mortality J:60609
Il4tm1(CD2)Mmrs/Il4tm1(CD2)Mmrs
involves: 129
decreased basophil cell number J:181313
decreased IgE level J:178986
decreased IgG1 level J:178986
decreased interleukin-4 secretion J:181313
Il4tm1(CD2)Mmrs/Il4tm1Lky
involves: 129/Sv * C57BL/6
no abnormal phenotype detected J:113279
Il4tm1.1Wep/Il4+
C.129P2-Il4tm1.1Wep
decreased IgE level J:138827
Il4tm1.1Wep/Il4tm1.1Wep
C.129P2-Il4tm1.1Wep
abnormal T-helper 2 cell differentiation J:138827
decreased IgE level J:138827
impaired eosinophil recruitment J:138827
Il4tm1.1Wep/Il4tm1.1Wep
involves: 129P2/OlaHsd * C57BL/6
decreased interleukin-4 secretion J:67964
Il4tm1Cgn/Il4tm1Cgn
B6.129P2-Il4tm1Cgn/J
abnormal skin physiology J:160119
normal immune system phenotype J:44346, J:160119
Il4tm1Cgn/Il4tm1Cgn
B6.Cg-Il4tm1Cgn
abnormal humoral immune response J:89095
abnormal T-helper 2 physiology J:89095
Il4tm1Cgn/Il4tm1Cgn
either: NOD.129-Il4tm1Cgn or (involves: 129 * NOD)
autoimmune response J:85924
insulitis J:85924
Il4tm1Cgn/Il4tm1Cgn
involves: 129P2/OlaHsd * A/WySn * C57BL/10SnSg * Swiss
abnormal physiological response to xenobiotic J:119207
decreased IgG1 level J:119207
increased IgG2a level J:119207
Il4tm1Cgn/Il4tm1Cgn
involves: 129P2/OlaHsd * C57BL/6
abnormal cytokine secretion J:704
decreased IgE level J:704
decreased IgG1 level J:704
granulomatous inflammation J:113543
Il4tm1Cgn/Il4tm1Cgn
involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp
decreased IgE level J:39600
decreased IgG1 level J:39600
Il4tm1Cgn/Il4tm1Cgn
involves: 129P2/OlaHsd * NOD
abnormal cytokine secretion J:85924
decreased IgG1 level J:85924
Il4tm1Cgn/Il4tm1Cgn
MRL.129P2-Il4tm1Cgn
lacrimal gland inflammation J:132514
Il4tm1Cgn/Il4tm1Cgn
NOD.129P2-Il4tm1Cgn
abnormal enzyme/coenzyme activity J:105803
abnormal salivary gland physiology J:105803
decreased susceptibility to autoimmune disorder J:95105
increased circulating glucose level J:95105
increased susceptibility to autoimmune disorder J:95105
Il4tm1Cgn/Il4tm1Cgn
NOD.Cg-H2b Il4tm1Cgn
abnormal enzyme/coenzyme activity J:105803
abnormal salivary gland physiology J:105803
lacrimal gland inflammation J:105803
salivary gland inflammation J:105803
Il4tm1Kopf/Il4tm1Kopf
involves: 129S2/SvPas
decreased eosinophil cell number J:113065
decreased IgE level J:113065
decreased interleukin-5 secretion J:113065
Il4tm1Kopf/Il4tm1Kopf
involves: 129S2/SvPas * C57BL/6
abnormal response to infection J:14593
decreased IgE level J:14593
decreased IgG1 level J:14593
decreased interleukin-3 secretion J:14593
decreased interleukin-4 secretion J:14593
decreased interleukin-5 secretion J:14593
decreased interleukin-10 secretion J:14593
increased IgG level J:14593
Il4tm1Nnt/Il4tm1Nnt
C57BL/6-Il4tm1Nnt/J
abnormal microglial cell morphology J:125605
abnormal T-helper 2 physiology J:37196
CNS inflammation J:125605
decreased IgE level J:37196
decreased IgG1 level J:37196
decreased IgM level J:37196
decreased interleukin-4 secretion J:37196
decreased interleukin-5 secretion J:37196
decreased interleukin-10 secretion J:37196, J:120556
granulomatous inflammation J:37196
increased IgA level J:37196
increased interferon-gamma secretion J:37196, J:120556
stomach inflammation J:120556
Il4tm1Nnt/Il4tm1Nnt
involves: C57BL/6
abnormal interleukin-4 secretion J:91403
decreased susceptibility to autoimmune disorder J:91403
Il4tm1Rao/Il4tm1Rao
involves: 129S6/SvEvTac * C57BL/6
abnormal mast cell physiology J:78089
abnormal T-helper 2 physiology J:78089
decreased interleukin-4 secretion J:78089
decreased interleukin-13 secretion J:78089
Il4tm2.1Kubo/Il4tm2.1Kubo
B6.Cg-Il4tm2.1Kubo
decreased airway responsiveness J:167446
decreased IgE level J:167446
decreased IgG1 level J:167446
decreased interleukin-4 secretion J:167446
impaired eosinophil recruitment J:167446
increased IgG2c level J:167446
increased interleukin-5 secretion J:167446
increased interleukin-13 secretion J:167446
Il4tm2Nnt/Il4tm2Nnt
BALB/c-Il4tm2Nnt
abnormal splenocyte physiology J:60609
abnormal susceptibility to infection J:60609
ileum inflammation J:60609
increased susceptibility to parasitic infection J:60609
increased susceptibility to parasitic infection induced morbidity/mortality J:60609
Il4tm2Nnt/Il4tm2Nnt
BALB/c-Il4tm2Nnt/J
abnormal dendritic cell antigen presentation J:141937
abnormal dendritic cell differentiation J:141937
abnormal kidney physiology J:84825
alveolar process atrophy J:147935
decreased IgE level J:31486
decreased IgG1 level J:31486
decreased interleukin-5 secretion J:141937
decreased interleukin-13 secretion J:141937
decreased susceptibility to autoimmune disorder J:141937
increased interferon-gamma secretion J:141937
Il4tm3.1Kubo/Il4tm3.1Kubo
B6.Cg-Il4tm3.1Kubo
decreased interleukin-4 secretion J:167446
Tg(KRT14-Il4)#Lsch/0
involves: BALB/cBy * C57BL/6
abnormal conjunctiva morphology J:126285
abnormal eyelid morphology J:126285
acanthosis J:126285
blepharitis J:126285
conjunctivitis J:126285
cornea scarring J:126285
decreased IgG2a level J:126285
dermatitis J:126285
dry skin J:126285
epidermal spongiosis J:126285
excessive scratching J:126285
hyperkeratosis J:126285
increased IgE level J:126285
increased IgG1 level J:126285
increased mast cell degranulation J:126285
increased pruritus J:126285
increased susceptibility to bacterial infection J:126285
parakeratosis J:126285
skin inflammation J:126285
spontaneous skin ulceration J:126285
Tg(LckIl4)1315Dbl/0
involves: C57BL/6J * DBA/2J
abnormal osteoblast physiology J:107359
abnormal osteoclast physiology J:107359
abnormal T cell activation J:92453
abnormal T cell differentiation J:92453
abnormal T cell number J:92453
abnormal thymocyte activation J:92453
abnormal thymus cell ratio J:92453
abnormal thymus morphology J:92453
absent CD8-positive, alpha-beta T cells J:92453
decreased bone strength J:107359
decreased CD4-positive, alpha-beta T cell number J:92453
decreased compact bone thickness J:107359
decreased double-positive T cell number J:92453
decreased trabecular bone mass J:107359
increased CD4-positive, alpha-beta T cell number J:92453
increased CD8-positive, alpha-beta T cell number J:92453
increased circulating phosphate level J:107359
increased diameter of femur J:107359
increased double-negative T cell number J:92453
increased IgG2a level J:92453
increased interleukin-4 secretion J:92453
increased susceptibility to parasitic infection J:92453
kyphosis J:107359
osteoporosis J:107359
thymus cortex hypoplasia J:92453
thymus hypoplasia J:92453

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory